Theravance reports third quarter 2014 financial results
Theravance reported the net loss for the third quarter of 2014 was $21.3 million or $0.19 per diluted share. Cash, cash equivalents, marketable securities and current restricted cash totaled $316.5 million as of September 30, 2014. October 30, 2014